Literature DB >> 18509053

Involvement of estrogen-related receptors in transcriptional response to hypoxia and growth of solid tumors.

Ada Ao1, Heiman Wang, Sushama Kamarajugadda, Jianrong Lu.   

Abstract

The development of intratumoral hypoxia is a universal hallmark of rapidly growing solid tumors. Adaptation to the hypoxic environment, which is critical for tumor cell survival and growth, is mediated primarily through a hypoxia-inducible factor (HIF)-dependent transcriptional program. HIF activates genes that facilitate crucial adaptive mechanisms including increased glucose uptake and glycolysis and tumor angiogenesis, making it an important therapeutic target. However, the HIF-dependent transcriptional mechanism remains incompletely understood, and targeting HIF is a difficult endeavor. Here, we show that the orphan nuclear receptor estrogen-related receptors (ERRs) physically interact with HIF and stimulate HIF-induced transcription. Importantly, ERRs appear to be essential for HIF's function. Transcriptional activation of hypoxic genes in cells cultured under hypoxia is largely blocked by suppression of ERRs through expression of a dominant negative form of ERR or treatment with a pharmacological ERR inhibitor, diethylstilbestrol. Systematic administration of diethylstilbestrol severely diminished growth and angiogenesis of tumor xenografts in vivo. Because nuclear receptors are outstanding targets for drug discovery, the findings not only may offer mechanistic insights into HIF-mediated transcription but also may open new avenues for targeting the HIF pathway for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18509053      PMCID: PMC2409389          DOI: 10.1073/pnas.0711677105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

Review 1.  Angiogenesis as a therapeutic target.

Authors:  Napoleone Ferrara; Robert S Kerbel
Journal:  Nature       Date:  2005-12-15       Impact factor: 49.962

2.  Two distinct types of repression domain in engrailed: one interacts with the groucho corepressor and is preferentially active on integrated target genes.

Authors:  E N Tolkunova; M Fujioka; M Kobayashi; D Deka; J B Jaynes
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

3.  Hypoxia-inducible factors 1alpha and 2alpha regulate trophoblast differentiation.

Authors:  Karen D Cowden Dahl; Benjamin H Fryer; Fiona A Mack; Veerle Compernolle; Emin Maltepe; David M Adelman; Peter Carmeliet; M Celeste Simon
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

4.  Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis.

Authors:  P P Peethambaram; J N Ingle; V J Suman; L C Hartmann; C L Loprinzi
Journal:  Breast Cancer Res Treat       Date:  1999-03       Impact factor: 4.872

5.  PGC-1alpha coactivates PDK4 gene expression via the orphan nuclear receptor ERRalpha: a mechanism for transcriptional control of muscle glucose metabolism.

Authors:  Adam R Wende; Janice M Huss; Paul J Schaeffer; Vincent Giguère; Daniel P Kelly
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

Review 6.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

Review 7.  Integration of oxygen signaling at the consensus HRE.

Authors:  Roland H Wenger; Daniel P Stiehl; Gieri Camenisch
Journal:  Sci STKE       Date:  2005-10-18

8.  Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression.

Authors:  Lawryn H Kasper; Fayçal Boussouar; Kelli Boyd; Wu Xu; Michelle Biesen; Jerold Rehg; Troy A Baudino; John L Cleveland; Paul K Brindle
Journal:  EMBO J       Date:  2005-10-20       Impact factor: 11.598

9.  Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway.

Authors:  Andrew L Kung; Sonya D Zabludoff; Dennis S France; Steven J Freedman; Elizabeth A Tanner; Annelisa Vieira; Susan Cornell-Kennon; Jennifer Lee; Beqing Wang; Jamin Wang; Klaus Memmert; Hans-Ulrich Naegeli; Frank Petersen; Michael J Eck; Kenneth W Bair; Alexander W Wood; David M Livingston
Journal:  Cancer Cell       Date:  2004-07       Impact factor: 31.743

10.  Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor.

Authors:  Takashi Suzuki; Yasuhiro Miki; Takuya Moriya; Norihiro Shimada; Takanori Ishida; Hisashi Hirakawa; Noriaki Ohuchi; Hironobu Sasano
Journal:  Cancer Res       Date:  2004-07-01       Impact factor: 12.701

View more
  53 in total

1.  The metabolic regulator ERRα, a downstream target of HER2/IGF-1R, as a therapeutic target in breast cancer.

Authors:  Ching-yi Chang; Dmitri Kazmin; Jeff S Jasper; Rebecca Kunder; William J Zuercher; Donald P McDonnell
Journal:  Cancer Cell       Date:  2011-10-18       Impact factor: 31.743

Review 2.  Tumor cell metabolism: an integral view.

Authors:  Susana Romero-Garcia; Jose Sullivan Lopez-Gonzalez; José Luis Báez-Viveros; Dolores Aguilar-Cazares; Heriberto Prado-Garcia
Journal:  Cancer Biol Ther       Date:  2011-12-01       Impact factor: 4.742

3.  A long AAAG repeat allele in the 5' UTR of the ERR-γ gene is correlated with breast cancer predisposition and drives promoter activity in MCF-7 breast cancer cells.

Authors:  C L Galindo; J F McCormick; V J Bubb; D H Abid Alkadem; Long-Shan Li; L J McIver; A C George; D A Boothman; J P Quinn; M A Skinner; H R Garner
Journal:  Breast Cancer Res Treat       Date:  2010-12-10       Impact factor: 4.872

4.  Targeted genes and interacting proteins of hypoxia inducible factor-1.

Authors:  Wei Liu; Shao-Ming Shen; Xu-Yun Zhao; Guo-Qiang Chen
Journal:  Int J Biochem Mol Biol       Date:  2012-05-31

5.  The Drosophila estrogen-related receptor directs a metabolic switch that supports developmental growth.

Authors:  Jason M Tennessen; Keith D Baker; Geanette Lam; Janelle Evans; Carl S Thummel
Journal:  Cell Metab       Date:  2011-02-02       Impact factor: 27.287

6.  Estrogen-related receptor alpha induces the expression of vascular endothelial growth factor in breast cancer cells.

Authors:  Rebecca A Stein; Stéphanie Gaillard; Donald P McDonnell
Journal:  J Steroid Biochem Mol Biol       Date:  2009-03-03       Impact factor: 4.292

Review 7.  Generating specificity and diversity in the transcriptional response to hypoxia.

Authors:  Urban Lendahl; Kian Leong Lee; Henry Yang; Lorenz Poellinger
Journal:  Nat Rev Genet       Date:  2009-11-03       Impact factor: 53.242

Review 8.  The obesity-related pathology and Th17 cells.

Authors:  Yusuke Endo; Koutaro Yokote; Toshinori Nakayama
Journal:  Cell Mol Life Sci       Date:  2016-10-18       Impact factor: 9.261

Review 9.  Potential of selective estrogen receptor modulators as treatments and preventives of breast cancer.

Authors:  Jing Peng; Surojeet Sengupta; V Craig Jordan
Journal:  Anticancer Agents Med Chem       Date:  2009-06       Impact factor: 2.505

10.  Increasing the number of thyroid lesions classes in microarray analysis improves the relevance of diagnostic markers.

Authors:  Jean-Fred Fontaine; Delphine Mirebeau-Prunier; Mahatsangy Raharijaona; Brigitte Franc; Stephane Triau; Patrice Rodien; Olivier Goëau-Brissonniére; Lucie Karayan-Tapon; Marielle Mello; Rémi Houlgatte; Yves Malthiery; Frédérique Savagner
Journal:  PLoS One       Date:  2009-10-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.